The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Sharp Phillip A since 2007.
This trader's CIK number is 1226295.
At the time of last reporting, Sharp Phillip A was the Director of Alnylam Pharmaceuticals, Inc.. (stock ticker symbol ALNY).
Also see all insider trading activities at Alnylam Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2008 | BIIB | 0 | $0 | 172,500 | $11,361,569 | 172,500 | $6,109,950 |
| 2007 | BIIB | 0 | $0 | 0 | $0 | 1,250 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ALNY | 0 | $0 | 11,250 | $3,093,750 | 11,250 | $1,476,112 |
| 2022 | ALNY | 0 | $0 | 33,670 | $7,741,810 | 33,670 | $1,581,648 |
| 2020 | ALNY | 0 | $0 | 60,000 | $7,672,140 | 60,000 | $653,400 |
| 2019 | ALNY | 0 | $0 | 30,000 | $2,722,470 | 30,000 | $577,800 |
| 2018 | ALNY | 0 | $0 | 30,000 | $4,170,000 | 30,000 | $729,450 |
| 2017 | ALNY | 0 | $0 | 55,000 | $2,136,025 | 55,000 | $1,491,750 |
| 2015 | ALNY | 0 | $0 | 30,000 | $3,270,000 | 30,000 | $431,850 |
| 2014 | ALNY | 0 | $0 | 110,000 | $9,350,000 | 110,000 | $816,750 |
| 2013 | ALNY | 4,967 | $99,985 | 0 | $0 | 0 | $0 |
| 2012 | ALNY | 9,302 | $99,996 | 0 | $0 | 0 | $0 |
2. Alnylam Pharmaceuticals, Inc. (ALNY)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-07-21 | BIIB | Sale | 72,500 | 68.00 | 4,930,000 |
| 2008-07-21 | BIIB | Option Ex | 72,500 | 35.42 | 2,567,950 |
| 2008-04-08 | BIIB | Option Ex | 100,000 | 35.42 | 3,542,000 |
| 2008-04-08 | BIIB | Sale | 76,850 | 64.20 | 4,933,616 |
| 2008-04-08 | BIIB | Sale | 15,650 | 64.63 | 1,011,428 |
| 2008-04-08 | BIIB | Sale | 7,500 | 64.87 | 486,525 |
| 2007-05-25 | BIIB | Option Ex | 1,250 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-01-23 | ALNY | Option Ex | 11,250 | 131.21 | 1,476,112 |
| 2025-01-23 | ALNY | Sale | 11,250 | 275.00 | 3,093,750 |
| 2022-08-15 | ALNY | Option Ex | 33,670 | 46.98 | 1,581,648 |
| 2022-08-15 | ALNY | Sale | 33,670 | 229.93 | 7,741,810 |
| 2020-11-25 | ALNY | Option Ex | 30,000 | 9.30 | 279,000 |
| 2020-11-25 | ALNY | Sale | 30,000 | 125.74 | 3,772,140 |
| 2020-02-12 | ALNY | Sale | 30,000 | 130.00 | 3,900,000 |
| 2020-02-12 | ALNY | Option Ex | 30,000 | 12.48 | 374,400 |
| 2019-11-18 | ALNY | Sale | 15,000 | 91.93 | 1,378,995 |
| 2019-11-18 | ALNY | Option Ex | 15,000 | 16.43 | 246,450 |
| 2019-04-15 | ALNY | Option Ex | 15,000 | 22.09 | 331,350 |
| 2019-04-15 | ALNY | Sale | 15,000 | 89.56 | 1,343,475 |
| 2018-03-13 | ALNY | Option Ex | 15,000 | 21.35 | 320,250 |
| 2018-03-13 | ALNY | Sale | 15,000 | 149.00 | 2,235,000 |
| 2018-03-09 | ALNY | Sale | 15,000 | 129.00 | 1,935,000 |
| 2018-03-09 | ALNY | Option Ex | 15,000 | 27.28 | 409,200 |
| 2017-02-01 | ALNY | Option Ex | 25,000 | 31.29 | 782,250 |
| 2017-02-01 | ALNY | Sale | 25,000 | 39.94 | 998,500 |
| 2017-01-25 | ALNY | Sale | 15,000 | 37.95 | 569,250 |
| 2017-01-25 | ALNY | Option Ex | 15,000 | 31.39 | 470,850 |
| 2017-01-18 | ALNY | Option Ex | 15,000 | 15.91 | 238,650 |
| 2017-01-18 | ALNY | Sale | 15,000 | 37.88 | 568,275 |
| 2015-12-04 | ALNY | Option Ex | 30,000 | 14.39 | 431,850 |
| 2015-12-04 | ALNY | Sale | 30,000 | 109.00 | 3,270,000 |
| 2014-10-13 | ALNY | Sale | 110,000 | 85.00 | 9,350,000 |
| 2014-10-13 | ALNY | Option Ex | 110,000 | 7.42 | 816,750 |
| 2013-01-22 | ALNY | Buy | 4,967 | 20.13 | 99,985 |
| 2012-02-21 | ALNY | Buy | 9,302 | 10.75 | 99,996 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Sharp Phillip A (Director of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.